Welcome Letter From John

Welcome to the CIG website. We are glad that you found us, and trust that you will find the information presented useful, whether you are a newly diagnosed patient, or an experienced one. In the world of non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are often under represented. In order to gather more information, patients who have become affected by this blood disorder need to group together and become more “visible” and vocal in the medical community. As a collective group, we’ll be in a better position to raise CLL/SLL awareness and better request resources dedicated to our needs.

New This Month

Premier Patient Education and Networking Forum in North America
Registration for the 13^th Annual North American Educational Forum on Lymphoma is now OPEN! This 2 1/2 day conference provides patients, survivors and loved ones with critical information about making the best decisions on treatment options, patient support issues and the latest in lymphoma research.

Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches
This free teleconference featuring Richard R. Furman, MD and Clive Zent, MD will be held on July 24, 2008 from 1:30pm – 2:30pm ET in collaboration with the Lymphoma Research Foundation and CancerCare.

Bendamustine (Treanda) Approved to Treat CLL
We interviewed Richard R. Furman, MD about the U.S. Food and Drug Administration's March approval of bendamustine to treat chronic lymphocytic leukemia (CLL).

FDA Approves New Drug for CLL
The U.S. Food and Drug Administration (FDA) approved bendamustine (Treanda) for the treatment of chronic lymphocytic leukemia.

CLL Highlights and What It Means for Patients
Every year scientists from around the world convene at the American Society of Hematology’s (ASH) annual meeting. The 2007 ASH meeting featured many abstracts on CLL. We interviewed John Byrd, MD to present the highlights on CLL and what it means for patients.

Patient Perspective: A CLL Diagnosis
A CLL diagnosis often leads to many challenges. This article is from the perspective of a long-term survivor and is about all that CLL carries along with it.

CLL Prognostic Markers: Latest Developments and What They Mean in Patient Outcome
We interviewed Bruce Cheson, MD about the latest developments in CLL prognostic markers and what they mean in patient outcome.

Patient Perspective: Diagnosis, Prognosis, Treatment and State of Mind
One Patient's Point of View by John Balan.

CLL Challenge Grant - $1.5 Million
The Lymphoma Research Foundation has received a $1.5 million CLL Challenge Grant from a generous donor as a result of the partnership with CIG. Contributions will be matched dollar for dollar.

CLL/SLL Publication - Order Your Free Copy Today
A new CLL/SLL-specific publication, Research In Focus: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, is available for free.

Subscribe to CLL/SLL Discussion Group

CIG is not a discussion group; it is a patient advocacy group that dispenses disease-specific information to people with CLL/SLL and their loved ones. However, we do have a related group where frequent and interesting discussions do take place. Richard Furman, MD, a CLL expert from Weill Medical College of Cornell University and New York-Presbyterian, is now active on this discussion group, so we have an important medical advisor on board. Subscribe to the discussion group today.

Join CIG

To receive regular updates from us about new content, news, and upcoming programs and events, please Join CIG.